[HTML][HTML] Global epidemiology of rheumatoid arthritis
Rheumatoid arthritis (RA) is a systemic autoimmune disease that predominantly affects the
joints. The prevalence of RA varies globally, with generally a higher prevalence in …
joints. The prevalence of RA varies globally, with generally a higher prevalence in …
Rheumatoid arthritis: extra-articular manifestations and comorbidities
FA Figus, M Piga, I Azzolin, R McConnell… - Autoimmunity reviews, 2021 - Elsevier
Although synovitis is the pathological hallmark of rheumatoid arthritis (RA), many extra-
articular manifestations (EMs) and comorbidities likely occur due to the complex, chronic …
articular manifestations (EMs) and comorbidities likely occur due to the complex, chronic …
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary …
Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …
exercising their clinical judgment, as well as in the determination and the implementation of …
Vascular inflammation and oxidative stress: major triggers for cardiovascular disease
S Steven, K Frenis, M Oelze, S Kalinovic… - Oxidative medicine …, 2019 - Wiley Online Library
Cardiovascular disease is a leading cause of death and reduced quality of life, proven by
the latest data of the Global Burden of Disease Study, and is only gaining in prevalence …
the latest data of the Global Burden of Disease Study, and is only gaining in prevalence …
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects
the lining of the synovial joints and is associated with progressive disability, premature …
the lining of the synovial joints and is associated with progressive disability, premature …
[HTML][HTML] Inflammation and cardiovascular disease: From mechanisms to therapeutics
Inflammation constitutes a complex, highly conserved cascade of molecular and cellular
events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical …
events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical …
[HTML][HTML] C-reactive protein and implications in rheumatoid arthritis and associated comorbidities
JE Pope, EH Choy - Seminars in arthritis and rheumatism, 2021 - Elsevier
C-reactive protein (CRP) is routinely assessed as a marker of systemic inflammation in
rheumatoid arthritis (RA). However, it is also an immune regulator that plays an important …
rheumatoid arthritis (RA). However, it is also an immune regulator that plays an important …
Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017
AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
JS Smolen, R Landewé, J Bijlsma… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international …
Against Rheumatism (EULAR) RA management recommendations. A large international …
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
D Van Der Heijde, S Ramiro, R Landewé… - Annals of the …, 2017 - ard.bmj.com
To update and integrate the recommendations for ankylosing spondylitis and the
recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial …
recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial …